Status:
UNKNOWN
Cluster Randomized Controlled Screening Trial for NPC
Lead Sponsor:
Sun Yat-sen University
Collaborating Sponsors:
Cancer Research Institute of Zhongshan City
Sihui Cancer Institute
Conditions:
Nasopharyngeal Cancer
Screening
Eligibility:
All Genders
30-69 years
Phase:
NA
Brief Summary
This study is aimed to estimate the effectiveness of an Epstein-Barr virus (EBV) serology-based screening program to reduce nasopharyngeal carcinoma (NPC) mortality in a cluster randomized controlled ...
Detailed Description
Nasopharyngeal carcinoma (NPC) has a high prevalence in southern China. Sihui and Zhongshan cities are located along the Pearl River in Guangdong Province, China, and are well known for a high inciden...
Eligibility Criteria
Inclusion
- Clusters
- Inclusion criteria 1) the town located in Sihui or Zhongshan city; 2) the town established a tertiary cancer prevention network; 3) the medical staff in the town hospitals agreed to take part in.
- Exclusion criteria 1) having conducted NPC screening program.
- Individuals
- Inclusion criteria 1) being aged 30-69 years; 2) being Cantonese; 3) having signed the informed consent; 4) having an Eastern Cooperative Oncology Group score of 0-2; and 5) having a good physical or psychological condition and consciousness.
- Exclusion criteria 1) having prevalent NPC.
Exclusion
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
87600 Patients enrolled
Trial Details
Trial ID
NCT00941538
Start Date
January 1 2008
End Date
December 1 2023
Last Update
February 28 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sihui Cancer Institute
Sihui, Guangdong, China
2
Cancer Research Institute of Zhongshan City
Zhongshan, Guangdong, China